Akero Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD for 2019

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Akero Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate for 2019.
  • Akero Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2019 $24K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.